Specification
Description
Pyrazoloacridine (NSC 366140), an intercalating agent with anti-cancer activity, inhibits the activity of topoisomerases 1 and 2. Pyrazoloacridine (NSC 366140) exhibits an IC50 of 1.25 μM in K562 myeloid leukemia cells for 24 h treatment.
Synonyms
Fluoren-9-yl-methyl-aether; 9-Methoxy-fluoren; 9-methoxyfluorene; fluoren-9-yl-methyl ether; 9-Methoxyellipticine; 9-methoxy-9H-fluorene; methoxyellipticine;
IUPAC Name
3-(9-Methoxy-5-nitropyrazolo[3,4,5-kl]acridin-2(1H)-yl)-N,N-dimet hyl-...
Canonical SMILES
CN(C)CCCN1C2=C3C(=C4C=C(C=CC4=NC3=C(C=C2)[N+](=O)[O-])OC)N1
InChI Key
HVRZAFDJOWIDMM-UHFFFAOYSA-N
Boiling Point
595.6ºC at 760 mmHg
Storage
Powder-20°C, 3 years; 4°C, 2 years; In solvent-80°C, 6 months; -20°C, 1 month.
Shipping
Can be shipped at room temperature, where not in use may vary.